
TearExo
Pioneering tear-based diagnostics for early disease detection and improved quality of life.
Date | Investors | Amount | Round |
---|---|---|---|
investor | €0.0 | round | |
investor investor investor investor | €0.0 | round | |
* | N/A | Early VC | |
Total Funding | 000k |
Related Content
TearExo is at the forefront of medical diagnostics, focusing on the innovative use of tears for early disease detection. Operating within the healthcare sector, the company targets both medical professionals and patients seeking non-invasive testing methods. By leveraging its proprietary technology, TearExo offers a pain-free alternative to traditional blood tests, aiming to enhance quality of life through early detection and treatment. The business model revolves around research and development, with potential revenue streams from partnerships, licensing, and direct sales of diagnostic kits. TearExo's commitment to advancing healthcare is underscored by its participation in international conferences, such as the Japan Anti Infectious Medical Association event, where it showcases its groundbreaking technology. Keywords: tear diagnostics, early detection, non-invasive testing, healthcare, quality of life, medical professionals, patients, research, technology, conferences.